Glucobrassicin-Brussel Sprout Effect on D10 Phe Metabolism
To determine whether glucobrassicin-rich Brussels sprouts can favorably modify the metabolism of the polycyclic aromatic hydrocarbon deuterated phenanthrene (\[D10\]phe) in current and former smokers
Checked against the public recordLast updated Feb 17, 2023 · Source: ClinicalTrials.gov
What this study is about
- Purpose
- Basic Science
- Study type
- Interventional
- Phase
- Phase 1
- Sponsor
- Masonic Cancer Center, University of Minnesota
- Interventions being studied
- Other: Brussel Sprouts; Drug: Deuterated Phenanthrene
How this study is categorized
These labels come from structured fields and exact terms in the public record.
Who may be able to participate
Inclusion Criteria: * Adult ≥ 18 years old * Current or former smoker by self-report * Willing to abstain from cruciferous vegetable consumption other than the study vegetable during the study period * Able to understand the experimental nature of the study and provide informed consent * Negative urine pregnancy test for women of childbearing potential within 7 days of baseline \[D10\]phe dosing Exclusion Criteria: * Chronic proton pump inhibitor, H2-blocker (i.e., ranitidine, famotidine), and/or calcium carbonate use * History of gastric bypass surgery, gastric banding, bowel resection, malabsorption syndromes such as celiac sprue or pancreatic insufficiency, or other conditions that may affect gastric absorption * Current use of tobacco products other than cigarettes (i.e. snuff, snuz, smokeless tobacco, cigars, pipes) or use of these products within 3 months of study registration * Major or chronic medical disease, including heart disease, poorly controlled diabetes, etc., to be adjudicated by the principal investigator * Women who are pregnant, intend to become pregnant within 3 months of the study period, or who are breastfeeding * Current or recent (within 12 months) problems with drug use or alcohol dependence by self-report Antibiotic use within 2 months of study enrollment or during the study by self-report Alcohol dependence, abuse, or history of dependence/abuse by self-report Vegetarians * History of respiratory tract cancer * Use of metronidazole or antabuse during the study * Taking ibuprofen, naproxen, other NSAIDs, steroids (except inhaled steroids) within 14 days of study registration * Allergy to Brussels sprouts
Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.
U.S. locations
- University of MinnesotaMinneapolis, Minnesota
Source and freshness
Processed from ClinicalTrials.gov. Last public update: Feb 17, 2023. Always confirm current availability with the study team.